Biosimilar granulocyte–colony‐stimulating factor for healthy donor stem cell mobilization: need we be afraid?

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|2|430-439

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.2, 2015-02, pp. : 430-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of hematopoietic stem cell yield after mobilization with granulocyte–colony‐stimulating factor in healthy unrelated donors

By  

TRANSFUSION, Vol. 55, Iss. 12, 2015-12 ,pp. : 2855-2863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biosimilar granulocyte–colony‐stimulating factor for mobilization of autologous peripheral blood stem cells in pediatric hematology‐oncology patients

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 246-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte–colony‐stimulating factor

By  

TRANSFUSION, Vol. 39, Iss. 5, 1999-05 ,pp. : 542-543

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severely elevated C‐reactive protein accompanied by prolonged high fever and leukocytosis in a healthy peripheral blood stem cell donor: an atypical granulocyte–colony‐stimulating factor reaction?

By  

TRANSFUSION, Vol. 55, Iss. 11, 2015-11 ,pp. : 2771-2772

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of Dutch guideline for just‐in‐time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte–colony‐stimulating factor

By  

TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. : 1021-1027

John Wiley & Sons Inc

Access to resources Recommend Favorite